首页> 外文OA文献 >Flavonoids as Therapeutic Agents in Alzheimer’s and Parkinson’s Diseases: A Systematic Review of Preclinical Evidences

【2h】

Flavonoids as Therapeutic Agents in Alzheimer’s and Parkinson’s Diseases: A Systematic Review of Preclinical Evidences

机译：黄酮类黄酮作为阿尔茨海默氏症和帕金森病的治疗剂：对临床前证据的系统审查

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Roxana Braga de Andrade Teles; Tâmara Coimbra Diniz; Tiago Coimbra Costa Pinto; Raimundo Gonçalves de Oliveira Júnior; Mariana Gama e Silva; Érica Martins de Lavor; Antonio Wilton Cavalcante Fernandes; Ana Paula de Oliveira; Fernanda Pires Rodrigues de Almeida Ribeiro; Amanda Alves Marcelino da Silva; Taisy Cinthia Ferro Cavalcante; Lucindo José Quintans Júnior; Jackson Roberto Guedes da Silva Almeida;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Flavonoids as Therapeutic Agents in Alzheimer’s and Parkinson’s Diseases: A Systematic Review of Preclinical Evidences [J] . Roxana Braga de Andrade Teles, Tmara Coimbra Diniz, Tiago Coimbra Costa Pinto, Oxidative Medicine and Cellular Longevity . 2018,第3期

机译：类黄酮作为阿尔茨海默氏症和帕金森氏病的治疗剂：对临床前证据的系统评价
2. A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer's and Parkinson's diseases [J] . Singh Yash Pal, Pandey Amruta, Vishwakarma Swati, Molecular diversity . 2019,第2期

机译：用于治疗阿尔茨海默和帕金森病的潜在治疗剂的铁螯合剂综述
3. Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease [J] . Jiang Tianfang, Sun Qian, Chen Shengdi Progress in Neurobiology: An International Review Journal . 2016,第Null期

机译：氧化应激：帕金森氏病和阿尔茨海默氏病的主要发病机理和抗氧化剂的潜在治疗靶标
4. Infectious Agents and Chronic Diseases: Further Evidence for a Viral Role in Alzheimer's Disease, and Possible Implications for Atherosclerotic Disease [C] . R. Itzhaki, M. Wozniak International Congress on Coronary Artery Disease . 2007

机译：传染病和慢性病：进一步证据在阿尔茨海默病中病毒作用，以及对动脉粥样硬化疾病的可能影响
5. Preclinical Evaluation of Water-Soluble Coenzyme Q10 for Therapeutic Treatment of Parkinson's Disease. [D] . Facecchia, Katie. 2012

机译：水溶性辅酶Q10在帕金森氏病治疗中的临床前评价。
6. Flavonoids as Therapeutic Agents in Alzheimers and Parkinsons Diseases: A Systematic Review of Preclinical Evidences [O] . Roxana Braga de Andrade Teles, Tâmara Coimbra Diniz, Tiago Coimbra Costa Pinto, 2018

机译：黄酮类化合物作为阿尔茨海默氏病和帕金森氏病的治疗剂：对临床前证据的系统评价
7. Preclinical Evidence and Possible Mechanisms of Baicalein for Rats and Mice With Parkinson's Disease: A Systematic Review and Meta-Analysis [O] . Yu Wang, Na Wei, Xiaoliang Li 2020

机译：帕金森病的大鼠和小鼠的临床前依据和可能的机制：系统评价和荟萃分析
8. Diagnosis and Treatment of Parkinson's Disease: A Systematic Review of the Literature. Evidence Report/Technology Assessment Number 57 [R] . Levine, C. B. , Fahrbach, K. R. , Estok, R. P. , 2003

机译：帕金森病的诊断和治疗：文献的系统评价。证据报告/技术评估编号57

Flavonoids as Therapeutic Agents in Alzheimer’s and Parkinson’s Diseases: A Systematic Review of Preclinical Evidences

著录项

引文网络

相似文献

相关主题

期刊订阅